Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations
Authors
Keywords
-
Journal
ONCOGENE
Volume 33, Issue 39, Pages 4724-4734
Publisher
Springer Nature
Online
2013-10-21
DOI
10.1038/onc.2013.418
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase II study of enzastaurin in combination with erlotinib in patients with previously treated advanced non-small cell lung cancer
- (2012) Christelle Clément-Duchêne et al. LUNG CANCER
- A placebo-controlled, randomized phase II study of maintenance enzastaurin following whole brain radiation therapy in the treatment of brain metastases from lung cancer
- (2012) Bjørn H. Grønberg et al. LUNG CANCER
- Protein Kinase C Inhibitor AEB071 Targets Ocular Melanoma Harboring GNAQ Mutations via Effects on the PKC/Erk1/2 and PKC/NF- B Pathways
- (2012) X. Wu et al. MOLECULAR CANCER THERAPEUTICS
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic and molecular characterization of uveal melanoma cell lines
- (2012) K. G. Griewank et al. Pigment Cell & Melanoma Research
- The Protein Kinase C Inhibitor Enzastaurin Exhibits Antitumor Activity against Uveal Melanoma
- (2012) Xinqi Wu et al. PLoS One
- Protein Kinase C Inhibitor Sotrastaurin Selectively Inhibits the Growth of CD79 Mutant Diffuse Large B-Cell Lymphomas
- (2011) T. L. Naylor et al. CANCER RESEARCH
- Phase II, Open-Label, Randomized Trial of the MEK1/2 Inhibitor Selumetinib as Monotherapy versus Temozolomide in Patients with Advanced Melanoma
- (2011) J. M. Kirkwood et al. CLINICAL CANCER RESEARCH
- Contribution of individual PKC isoforms to breast cancer progression
- (2011) Alejandro J. Urtreger et al. IUBMB LIFE
- Fine Tuning of Protein Kinase C (PKC) Isoforms in Cancer: Shortening the Distance from the Laboratory to the Bedside
- (2011) R. Bosco et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Resistance to BRAF Inhibition in Melanomas
- (2011) David B. Solit et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy
- (2010) K H T Paraiso et al. BRITISH JOURNAL OF CANCER
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
- (2010) Cory M. Johannessen et al. NATURE
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
- (2010) Ramin Nazarian et al. NATURE
- Mutations inGNA11in Uveal Melanoma
- (2010) Catherine D. Van Raamsdonk et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Mammalian MAPK/ERK Pathway Exhibits Properties of a Negative Feedback Amplifier
- (2010) O. E. Sturm et al. Science Signaling
- Discovery of 3-(1H-Indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (AEB071), a Potent and Selective Inhibitor of Protein Kinase C Isotypes
- (2009) Jürgen Wagner et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synergistic drug combinations tend to improve therapeutically relevant selectivity
- (2009) Joseph Lehár et al. NATURE BIOTECHNOLOGY
- Mutational Profile of GNAQQ209 in Human Tumors
- (2009) Simona Lamba et al. PLoS One
- V600EBRAF is associated with disabled feedback inhibition of RAF-MEK signaling and elevated transcriptional output of the pathway
- (2009) C. A. Pratilas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Elevated CRAF as a Potential Mechanism of Acquired Resistance to BRAF Inhibition in Melanoma
- (2008) C. Montagut et al. CANCER RESEARCH
- BRAF V600E Disrupts AZD6244-Induced Abrogation of Negative Feedback Pathways between Extracellular Signal-Regulated Kinase and Raf Proteins
- (2008) B. B. Friday et al. CANCER RESEARCH
- Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
- (2008) Catherine D. Van Raamsdonk et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started